Implantable Biomaterials Global market - Forecast to 2022

Publishing Date : December, 2016
Report Code : HCMD0141
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Note: The report would be dispatched after confirmation of payment

A biomaterial is any substance of metallic, polymer, ceramic or natural origin that is suitable for introducing into living tissue as an implant without adversely affecting the patient. The biomaterial implants have been enormously successful and have enhanced the life of millions of patients. There is continuous ongoing research to develop next generation advanced biomaterials like bioabsorbable materials, bioactive and smart biomaterials, shape memory biomaterials etc. Next generation of biomaterials will have better prospect from the current research and innovations taking placing in biomaterials field.

This report concentrates on biomaterials that are used in the manufacturing of implant devices. The non-implant devices like catheters, guide wires and biomaterials in tissue engineering are not considered in implantable biomaterials report. Also, autografts and xenograft are not taken into account, only mass manufacture biomaterials are described in the report.

The Implantable Biomaterials market is classified based on type of materials, application, and geography. By material type, the market is segmented into Metal and Metal alloys, Synthetic Polymers, Ceramics, Natural biomaterials and Composites. By application, implantable biomaterials market is segmented into Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Ophthalmology, Neurology and other Applications. Geographical wise, the transplantation market is segmented into North America, Europe, Asia- Pacific and Rest of the world.

Among the implantable biomaterials by type, the synthetic polymers are dominating the market by occupying a largest share and synthetic polymers are expected to grow at a highest CAGR from 2015 to 2022. The synthetic polymers market by type is segmented into Polyetheretherketone, polytetrafluoroethylene, Polyethylene terephthalate, Polyethylene, Polymethylmethacrylate, Polyurethanes, Silicone, Resorbable polymers, Hydrogels and others. Among these, Polyetheretherketone accounts for major share in synthetic polymers segment and Resorbable polymers are expected to grow at strong CAGR from 2016 to 2023. By applications, the market is segmented into Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Ophthalmology, Neurology and other Applications. Among these, Orthopedic application accounts for largest share of application market and Wound healing is growing at strong CAGR from 2016 to 2023.

The global implantable biomaterials market is expected to grow at single digit CAGR to reach $21,124.2 million by 2022. The factors driving the growth of this market are increasing ageing population, increase in Research and development investments, increasing applications of biomaterials, growing demand for plastic surgery, and reimbursements offered by Center for Medicare and Medicaid Services. However, stringent regulatory processes for approval of biomaterials and biomaterials based implant devices and limitations of biomaterials like complications due to implant rejection, cytotoxicity, and corrosion of biomaterials implant are hampering the growth of implantable biomaterials market.

The implantable biomaterials market is a highly fragmented market. Major players in Biomaterial market include Solvay Advanced Polymers, LLC (Belgium), Evonik Industries AG (Germany), Carpenter Technology Corporation (U.S.), DSM Biomedical, Inc. (Royal DSM) (Netherlands), Johnson Matthey Plc (U.K.), Morgan Advanced Materials plc (U.K.), Materion (U.S.), Victrex  PLC (Invibio Biomaterial Solutions) (U.K.) and Collagen solutions (U.K.), Corbion N.V. (Netherlands), Landec Corporation (U.S.).

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     PRIMARY SOURCES
      • 2.5.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     ADVANCES IN 3D PRINTING OF BIOMATERIALS
        • 3.3.1.2     INCREASING AGING POPULATION
        • 3.3.1.3     MINIATURIZATION OF IMPLANT DEVICES AND INCREASING MINIMALLY INVASIVE SURGERY
        • 3.3.1.4     DEMAND FOR ORTHOPEDIC IMPLANTS
        • 3.3.1.5     INCREASING R&D INVESTMENTS
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     LIMITATIONS OF BIOMATERIAL-BASE PRODUCTS
        • 3.3.2.2     STRINGENT REGULATORY PROCESSES FOR APPROVAL OF BIOMATERIALS & BIOMATERIAL BASED PRODUCTS
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
      • 3.4.2     U.S.
      • 3.4.3     EUROPE
      • 3.4.4     CHINA
      • 3.4.5     CANADA
      • 3.4.6     INDIA
    • 3.5     TECHNOLOGICAL ADVANCEMENTS
      • 3.5.1     INTRODUCTION
      • 3.5.2     SMART BIOMATERIALS
      • 3.5.3     SHEAR-THINNING BIOMATERIALS (STB)
    • 3.6     PORTER’S FIVE FORCE ANALYSIS
      • 3.6.1     THREAT OF NEW ENTRANTS
      • 3.6.2     THREAT OF SUBSTITUTES
      • 3.6.3     BARGAINING POWER OF SUPPLIERS
      • 3.6.4     BARGAINING POWER OF BUYERS
      • 3.6.5     RIVALRY AMONG EXISTING COMPETITORS
    • 3.7     SUPPLY CHAIN ANALYSIS
    • 3.8     MARKET SHARE ANALYSIS BY MAJOR PLAYERS
  • 4     IMPLANTABLE BIOMATERIALS GLOBAL MARKET, BY TYPE
    • 4.1     INTRODUCTION
    • 4.2     METALS AND METAL ALLOYS
      • 4.2.1     TITANIUM AND TITANIUM ALLOYS
      • 4.2.2     COBALT-CHROME ALLOYS
      • 4.2.3     STAINLESS STEEL
      • 4.2.4     MAGNESIUM AND MAGNESIUM ALLOYS
      • 4.2.5     OTHER METALLIC BIOMATERIALS
    • 4.3     SYNTHETIC POLYMERS
      • 4.3.1     INTRODUCTION
      • 4.3.2     POLYETHERETHERKETONE (PEEK)
      • 4.3.3     POLYTETRAFLU0ROETHYLENE (PTFE)
      • 4.3.4     POLYETHYLENE TEREPHTHALATE (PETE)
      • 4.3.5     POLYETHYLENE (UHMWPE)
      • 4.3.6     POLYMETHYLMETHACRYLATE (PMMA)
      • 4.3.7     POLYURETHANES
      • 4.3.8     SILICONE
      • 4.3.9     RESORBABLE POLYMERS
      • 4.3.10     HYDROGELS
      • 4.3.11     OTHER SYNTHETIC POLMERS
    • 4.4     CERAMICS
      • 4.4.1     CALCIUM COMPOSITIONS
      • 4.4.2     ALUMINUM OXIDE
      • 4.4.3     ZIRCONIA
      • 4.4.4     CARBON
      • 4.4.5     GLASS
      • 4.4.6     SILICON NITRIDE
    • 4.5     NATURAL BIOMATERIALS
      • 4.5.1     INTRODUCTION
      • 4.5.2     CELLULOSE
      • 4.5.3     COLLAGEN AND GELATIN
      • 4.5.4     HYALURONIC ACID
      • 4.5.5     FIBRIN
      • 4.5.6     CHITIN/CHITOSAN
      • 4.5.7     ELASTIN
      • 4.5.8     SILK
      • 4.5.9     OTHER NATURAL BIOMATERIALS
    • 4.6     COMPOSITES
  • 5     IMPLANTABLE BIOMATERIALS GLOBAL MARKET, BY APPLICATION
    • 5.1     INTRODUCTION
    • 5.2     CARDIOVASCULAR
      • 5.2.1     STENTS
      • 5.2.2     HEART VALVE REPAIR AND REPLACEMENT
      • 5.2.3     VASCULAR GRAFTS
      • 5.2.4     PACMAKERS AND IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICDS)
      • 5.2.5     OTHERS
    • 5.3     ORTHOPEDIC APPLICATION
      • 5.3.1     JOINT REPAIR AND REPLACEMENT
      • 5.3.2     SPINE
      • 5.3.3     ORTHOBIOLOGICS
      • 5.3.4     OTHER ORTHOPEDIC APPLICATION
    • 5.4     DENTAL
      • 5.4.1     DENTAL IMPLANTS
      • 5.4.2     DENTAL BONE GRAFTS AND SUBSTITUTES
      • 5.4.3     DENTAL MEMBRANES
    • 5.5     PLASTIC SURGERY
      • 5.5.1     BIOENGINEERED SKINS
      • 5.5.2     SOFT TISSSUE FILLERS
      • 5.5.3     COSMETIC IMPLANTS
      • 5.5.4     CRANIOFACIAL SURGERY
    • 5.6     WOUND HEALING
      • 5.6.1     WOUND CLOSURE
        • 5.6.1.1     SUTURES
        • 5.6.1.2     STAPLES
        • 5.6.1.3     LIGATING CLIPS
      • 5.6.2     SYNTHETIC SKIN SUBSTITUTES
      • 5.6.3     TAPES AND ADHESIVES
      • 5.6.4     HEMOSTATS
      • 5.6.5     SEALANTS
    • 5.7     OPHTHALMOLOGY
      • 5.7.1     CONTACT LENS
      • 5.7.2     INTRAOCULAR LENS
      • 5.7.3     OCULAR REPLACEMENT
      • 5.7.4     SYNTHETIC CORNEA
      • 5.7.5     VITREOUS BODY REPLACEMENT
    • 5.8     NEUROLOGY APPLICATIONS
      • 5.8.1     SHUNTING SYSTEMS
      • 5.8.2     CORTICAL NEURAL PROSTHETICS
      • 5.8.3     NERVE CONDUITS
    • 5.9     OTHER APPLICATIONS
      • 5.9.1     GASTROINTESTINAL
      • 5.9.2     SURGICAL MESH
      • 5.9.3     COCHLEAR IMPLANT
      • 5.9.4     IMPLANTABLE INFUSION PUMPS
      • 5.9.5     OTHER STENTS AND VASCULAR GRAFTS
      • 5.9.6     OTHERS
  • 6     REGIONAL ANALYSIS
    • 6.1     INTRODUCTION
    • 6.2     NORTH AMERICA
      • 6.2.1     U.S.
      • 6.2.2     OTHERS
    • 6.3     EUROPE
      • 6.3.1     GERMANY
      • 6.3.2     U.K.
      • 6.3.3     FRANCE
      • 6.3.4     OTHERS
    • 6.4     ASIA - PACIFIC
      • 6.4.1     JAPAN
      • 6.4.2     CHINA
      • 6.4.3     INDIA
      • 6.4.4     OTHERS
    • 6.5     REST OF THE WORLD
      • 6.5.1     LATIN AMERICA
      • 6.5.2     MIDDLE EAST
      • 6.5.3     OTHERS
  • 7     MAJOR COMPANIES
    • 7.1     CARPENTER TECHNOLOGY CORPORATION
      • 7.1.1     OVERVIEW
      • 7.1.2     FINANCIALS
      • 7.1.3     PRODUCT PORTFOLIO
      • 7.1.4     KEY DEVELOPMENTS
      • 7.1.5     BUSINESS STRATEGY
      • 7.1.6     SWOT ANALYSIS
    • 7.2     COLLAGEN SOLUTIONS
      • 7.2.1     OVERVIEW
      • 7.2.2     FINANCIALS
      • 7.2.3     PRODUCT PORTFOLIO
      • 7.2.4     KEY DEVELOPMENTS
      • 7.2.5     BUSINESS STRATEGY
      • 7.2.6     SWOT ANALYSIS
    • 7.3     CORBION NV
      • 7.3.1     OVERVIEW
      • 7.3.2     FINANCIALS
      • 7.3.3     PRODUCT PORTFOLIO
      • 7.3.4     KEY DEVELOPMENTS
      • 7.3.5     BUSINESS STRATEGY
      • 7.3.6     SWOT ANALYSIS
    • 7.4     EVONIK INDUSTRIES AG
      • 7.4.1     OVERVIEW
      • 7.4.2     FINANCIALS
      • 7.4.3     PRODUCT PORTFOLIO
      • 7.4.4     KEY DEVELOPMENTS
      • 7.4.5     BUSINESS STRATEGY
      • 7.4.6     SWOT ANALYSIS
    • 7.5     JOHNSON MATTHEY PLC
      • 7.5.1     OVERVIEW
      • 7.5.2     FINANCIALS
      • 7.5.3     PRODUCT PORTFOLIO
      • 7.5.4     KEY DEVELOPMENTS
      • 7.5.5     BUSINESS STRATEGY
      • 7.5.6     SWOT ANALYSIS
    • 7.6     LANDEC CORPORATION
      • 7.6.1     OVERVIEW
      • 7.6.2     FINANCIALS
      • 7.6.3     PRODUCT PORTFOLIO
      • 7.6.4     KEY DEVELOPMENTS
      • 7.6.5     BUSINESS STRATEGY
      • 7.6.6     SWOT ANALYSIS
    • 7.7     MATERION CORPORATION
      • 7.7.1     OVERVIEW
      • 7.7.2     FINANCIALS
      • 7.7.3     PRODUCT PORTFOLIO
      • 7.7.4     KEY DEVELOPMENTS
      • 7.7.5     BUSINESS STRATEGY
      • 7.7.6     SWOT ANALYSIS
    • 7.8     MORGAN ADVANCED MATERIALS PLC
      • 7.8.1     OVERVIEW
      • 7.8.2     FINANCIALS
      • 7.8.3     PRODUCT PORTFOLIO
      • 7.8.4     KEY DEVELOPMENTS
      • 7.8.5     BUSINESS STRATEGY
      • 7.8.6     SWOT ANALYSIS
    • 7.9     ROYAL DSM BIOMEDICAL
      • 7.9.1     OVERVIEW
      • 7.9.2     FINANCIALS
      • 7.9.3     PRODUCT PORTFOLIO
      • 7.9.4     KEY DEVELOPMENTS
      • 7.9.5     BUSINESS STRATEGY
      • 7.9.6     SWOT ANALYSIS
    • 7.10     SOLVAY SA
      • 7.10.1     OVERVIEW
      • 7.10.2     FINANCIALS
      • 7.10.3     PRODUCT PORTFOLIO
      • 7.10.4     KEY DEVELOPMENTS
      • 7.10.5     BUSINESS STRATEGY
      • 7.10.6     SWOT ANALYSIS
    • 7.11     VICTREX PLC
      • 7.11.1     OVERVIEW
      • 7.11.2     FINANCIALS
      • 7.11.3     PRODUCT PORTFOLIO
      • 7.11.4     KEY DEVELOPMENTS
      • 7.11.5     BUSINESS STRATEGY
      • 7.11.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     IMPLANTABLE BIOMATERIALS GLOBAL MARKET REVENUE, BY REGION, (2014 - 2022) ($MN)
      • TABLE 2     IMPLANTABLE BIOMATERIALS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 3     METALIC IMPLANTABLE BIOMATERIALS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 4     METALLIC IMPLANTABLE BIOMATERIALS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 5     TITANIUM AND TITANIUM ALLOY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 6     COBALT-CHROME ALLOYS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 7     STAINLESS STEEL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 8     MAGNESIUM AND MAGNESIUM ALLOYS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 9     OTHER METALLIC IMPLANTABLE BIOMATERIALS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 10     SYNTHETIC POLYMERS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 11     SYNTHETIC POLYMERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 12     POLYETHERETHERKETONE (PEEK) GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 13     POLYTETRAFLUOROETHYLENE (PTFE) GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 14     POLYETHYLENE TEREPHTHALATE (PETE) GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 15     POLYETHYLENE (UHMWPE) GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 16     POLYMETHYLMETHACRYLATE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 17     POLYURETHANES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 18     SILICONE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 19     RESORBABLE POLYMERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 20     HYDROGELS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 21     OTHER SYNTHETIC POLYMERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 22     CERAMICS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 23     CERAMICS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 24     CALCIUM COMPOSITIONS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 25     ALUMINIUM OXIDE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 26     ZIRCONIA GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 27     CARBON GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 28     GLASS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 29     SILICON NITRIDE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 30     NATURAL IMPLANTABLE BIOMATERIALS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 31     NATURAL IMPLANTABLE BIOMATERIALS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 32     CELLULOSE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 33     COLLAGEN AND GELATIN GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 34     HYALURONIC ACID GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 35     FIBRIN GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 36     CHITIN GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 37     ELASTIN GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 38     SILK GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 39     OTHER NATURAL IMPLANTABLE BIOMATERIALS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 40     COMPOSITES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 41     IMPLANTABLE BIOMATERIALS GLOBAL MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 42     CARDIOVASCULAR APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 43     CARDIOVASCULAR APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 44     STENT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 45     HEART VALVE REPAIR AND REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 46     VASCULAR GRAFT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 47     PACEMAKERS AND ICDS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 48     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 49     ORTHOPEDIC GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 50     ORTHOPEADIC GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 51     JOINT REPAIR AND REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 52     SPINE GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 53     ORTHOBIOLOGICS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 54     OTHER ORTHOPEDIC APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 55     DENTAL GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 56     DENTAL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 57     DENTAL IMPLANTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 58     DENTAL BONE GRAFTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 59     DENTAL MEMBRANES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 60     PLASTIC SURGERY GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 61     PLASTIC SURGERY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 62     BIOENGINEERED SKIN GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 63     SOFT TISSUE FILLERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 64     COSMETIC IMPLANTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 65     CRANIOFACIAL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 66     WOUND HEALING GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 67     WOUND HEALING GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 68     WOUND CLOSURE GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 69     WOUND CLOSURE GLOBAL MARKET REVENUE, BY REGON, (2014-2022) ($MN)
      • TABLE 70     SUTURES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 71     STAPLES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 72     LIGATING CLIPS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 73     SYNTHETIC SKIN SUBSTITUTES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 74     TAPES AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 75     HEMOSTATS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 76     GLOBAL SEALANTS MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 77     OPHTHALMOLOGY GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 78     OPHTHALMOLOGY GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 79     CONTACT LENS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 80     INTRAOCULAR LENS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 81     OCULAR REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 82     ARTIFICIAL CORNEA GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 83     VITREOUS BODY REPLACEMENT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 84     NEUROLOGY APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 85     NEUROLOGY APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 86     SHUNTING SYSTEMS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 87     CORTICAL NEURAL PROSTHETICS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 88     NERVE CONDUITS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 89     OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 90     OTHER APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 91     GASTROINTESTINAL GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 92     SURGICAL MESH GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 93     COCHLEAR IMPLANT GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 94     IMPLANTABLE INFUSION PUMPS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 95     OTHER STENTS AND VASCULAR GRAFTS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 96     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 97     IMPLANTABLE BIOMATERIALS GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
      • TABLE 98     NORTH AMERICAN IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 99     NORTH AMERICAN IMPLANTABLE METALLIC BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 100     NORTH AMERICAN IMPLANTABLE SYNTHETIC POLYMERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 101     NORTH AMERICAN CERAMIC IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 102     NORTH AMERICAN NATURAL BIOMATIERALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 103     NORTH AMERICAN IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 104     NORTH AMERICAN CARDIOVASCULAR APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 105     NORTH AMERICAN ORTHOPEDIC APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 106     NORTH AMERICAN DENTAL APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 107     NORTH AMERICAN PLASTIC SURGERY APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 108     NORTH AMERICAN WOUND HEALING MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 109     NORTH AMERICAN WOUND CLOSURE APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 110     NORTH AMERICAN OPHTHALMOLOGY MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 111     NORTH AMERICAN NEUROLOGY APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 112     NORTH AMERICAN OTHER APPLICATIONS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 113     NORTH AMERICAN IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY COUNTRY, (2014-2022) ($MN)
      • TABLE 114     U.S. IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 115     U.S IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 116     OTHERS NORTH AMERICAN MARKET REVENUE, BY TYPE, (2015 V/S 2022) ($MN)
      • TABLE 117     OTHERS NORTH AMERICAN MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 118     EUROPEAN IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 119     EUROPEAN METALLIC IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 120     EUROPEAN SYNTHETIC POLYMERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 121     EUROPEAN CERAMIC IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 122     EUROPEAN NATURAL BIOMATIERALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 123     EUROPEAN IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 124     EUROPEAN CARDIOVASCULAR APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 125     EUROPEAN ORTHOPEDIC APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 126     EUROPEAN DENTAL APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 127     EUROPEAN PLASTIC SURGERY APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 128     EUROPEAN WOUND HEALING MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 129     EUROPEAN WOUND CLOSURE APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 130     EUROPEAN OPHTHALMOLOGY MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 131     EUROPEAN NEUROLOGY APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 132     EUROPEAN OTHER APPLICATIONS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 133     EUROPEAN IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY COUNTRY, (2014-2022) ($MN)
      • TABLE 134     GERMANY IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 135     GERMANY IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 136     U.K. IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 137     U.K. IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 138     FRANCE IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 139     FRANCE IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 140     OTHER EUROPEAN COUNTRIES IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 141     OTHER EUROPEAN COUNTRIES IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 142     ASIA-PACIFIC IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 143     ASIA-PACIFIC METALLIC IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 144     ASIA-PACIFIC IMPLANTABLE SYNTHETIC POLYMERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 145     ASIA-PACIFIC CERAMIC IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 146     ASIA-PACIFIC NATURAL BIOMATIERALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 147     ASIA-PACIFIC IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 148     ASIA-PACIFIC CARDIOVASCULAR APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 149     ASIA-PACIFIC ORTHOPEDIC APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 150     ASIA-PACIFIC DENTAL APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 151     ASIA-PACIFIC PLASTIC SURGERY APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 152     ASIA-PACIFIC WOUND HEALING MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 153     ASIA-PACIFIC WOUND CLOSURE APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 154     ASIA-PACIFIC OPHTHALMOLOGY MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 155     ASIA-PACIFIC NEUROLOGY APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 156     ASIA-PACIFIC OTHER APPLICATIONS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 157     ASIA-PACIFIC IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY COUNTRY, (2014-2022) ($MN)
      • TABLE 158     JAPAN IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 159     JAPAN IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 160     CHINA IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 161     CHINA IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 162     INDIA IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 163     INDIA IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 164     OTHERS IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 165     OTHERS IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 166     ROW IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 167     ROW METALLIC IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 168     ROW IMPLANTABLE SYNTHETIC POLYMERS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 169     ROW CERAMIC IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 170     ROW NATURAL BIOMATIERALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 171     ROW IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 172     ROW CARDIOVASCULAR APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 173     ROW ORTHOPEDIC APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 174     ROW DENTAL APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 175     ROW PLASTIC SURGERY APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 176     ROW WOUND HEALING MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 177     ROW WOUND CLOSURE APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 178     ROW OPHTHALMOLOGY MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 179     ROW NEUROLOGY APPLICATION MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 180     ROW OTHER APPLICATIONS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 181     ROW IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY COUNTRY, (2014-2022) ($MN)
      • TABLE 182     LATIN AMERICA IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 183     LATIN AMERICA IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 184     MIDDLE EAST IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 185     MIDDLE EAST IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 186     OTHERS IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2014-2022) ($MN)
      • TABLE 187     OTHERS IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2014-2022) ($MN)
      • TABLE 188     CARPENTER TECHNOLOGY CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 189     CARPENTER TECHNOLOGY CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 190     CARPENTER TECHNOLOGY CORPORTATION: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 191     COLLAGEN SOLUTIONS PLC : TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 192     COLLAGEN SOLUTIONS PLC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 193     CORBION NV: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 194     CORBION NV: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 195     CORBION NV: TOTAL REVENUE, BY BIOBASED INGREDIENTS SUB-SEGMENTS, (2014-2016) ($MN)
      • TABLE 196     CORBION NV: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 197     EVONIK INDUSTRIES AG : TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 198     EVONIK INDUSTRIES AG: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 199     EVONIK INDUSTRIES AG: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 200     JOHNSON MATTHEY PLC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 201     JOHNSON MATTHEY PLC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 202     JOHNSON MATTHEY PLC: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 203     LANDEC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 204     LANDEC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 205     MATERION CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2013-2015) ($MN)
      • TABLE 206     MATERION CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 207     MATERION CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 208     MORGAN ADVANCED MATERIALS PLC : TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 209     MORGAN ADVANCED MATERIALS PLC: TOTAL REVENUE, BY SEGMENTS, (2013-2015) ($MN)
      • TABLE 210     MORGAN ADVANCED MATERIALS PLC: TOTAL REVENUE, BY GEOGRAPHY, (2013-2015) ($MN)
      • TABLE 211     ROYAL DSM BIOMEDICAL, INC. : TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 212     ROYAL DSM BIOMEDICAL, INC.: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 213     ROYAL DSM BIOMEDICAL, INC.: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 214     SOLVAY ADVANCED POLYMER, LLC : TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 215     SOLVAY ADVANCED POLYMER,LLC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 216     SOLVAY ADVANCED POLYMER,LLC: TOTAL REVENUE, BY SUB-SEGMENTS, (2014-2016) ($MN)
      • TABLE 217     SOLVAY ADVANCED POLYMER,LLC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 218     VICTREX PLC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 219     VICTREX PLC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 220     VICTREX PLC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)

      LIST OF FIGURES

      • FIGURE 1     IMPLANTABLE BIOMATERIALS GLOBAL MARKET REVENUE, BY REGION (2014-2022) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: IMPLANTABLE BIOMATERIALS GLOBAL MARKET
      • FIGURE 3     IMPLANTABLE BIOMATERIALS GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     IMPLANTABLE BIOMATERIALS GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     IMPLANTABLE BIOMATERIALS GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     IMPLANTABLE BIOMATERIALS GLOBAL MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     IMPLANTABLE BIOMATERIALS GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 9     IMPLANTABLE BIOMATERIALS GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     IMPLANTABLE BIOMATERIALS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2015 (%)
      • FIGURE 11     IMPLANTABLE BIOMATERIALS GLOBAL MARKET REVENUE, BY TYPE, (2014 - 2022) ($MN)
      • FIGURE 12     METALLIC IMPLANTABLE BIOMATERIALS GLOBAL MARKET REVENUE, BY TYPE (2014 - 2022) ($MN)
      • FIGURE 13     METALLIC IMPLANTABLE BIOMATERIALS GLOBAL MARKET REVENUE, BY REGION, (2015 V/S 2022) ($MN)
      • FIGURE 14     SYNTHETIC POLYMERS GLOBAL MARKET REVENUE, BY TYPE, (2015 V/S 2022) ($MN)
      • FIGURE 15     SYNTHETIC POLMERS GLOBAL MARKET REVENUE, BY REGION, (2015 V/S 2022) ($MN)
      • FIGURE 16     CERAMICS GLOBAL MARKET REVENUE, BY TYPE (2014 - 2022) ($MN)
      • FIGURE 17     CERAMICS GLOBAL MARKET REVENUE, BY REGION, (2015 V/S 2022) ($MN)
      • FIGURE 18     NATURAL IMPLANTABLE BIOMATERIALS GLOBAL MARKET REVENUE, BY TYPE (2015 V/S 2022) ($MN)
      • FIGURE 19     NATURAL IMPLANTABLE BIOMATERIALS GLOBAL MARKET REVENUE, BY REGION, (2015 V/S 2022) ($MN)
      • FIGURE 20     COMPOSITES GLOBAL MARKET REVENUE, BY REGION, (2015 V/S 2022) ($MN)
      • FIGURE 21     IMPLANTABLE BIOMATERIALS GLOBAL MARKET REVENUE, BY APPLICATION, (2015 V/S 2022) ($MN)
      • FIGURE 22     CARDIOVASCULAR APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2014 - 2022) ($MN)
      • FIGURE 23     ORTHOPEADIC GLOBAL MARKET REVENUE, BY TYPE, (2014 - 2022) ($MN)
      • FIGURE 24     ORTHOPEADIC GLOBAL MARKET REVENUE, BY REGION, (2015 V/S 2022) ($MN)
      • FIGURE 25     DENTAL GLOBAL MARKET REVENUE, BY TYPE, (2014 - 2022) ($MN)
      • FIGURE 26     PLASTIC SURGERY GLOBAL MARKET REVENUE, BY TYPE, (2014 - 2022) ($MN)
      • FIGURE 27     WOUND HEALING GLOBAL MARKET REVENUE, BY TYPE, (2014 - 2022) ($MN)
      • FIGURE 28     WOUND HEALING GLOBAL MARKET REVENUE, BY REGION, (2015 V/S 2022) ($MN)
      • FIGURE 29     OPTHALMOLOGY GLOBAL MARKET REVENUE, BY TYPE (2014 - 2022) ($MN)
      • FIGURE 30     NEUROLOGY APPLICATION GLOBAL MARKET REVENUE, BY TYPE, (2014 - 2022) ($MN)
      • FIGURE 31     OTHER APPLICATIONS GLOBAL MARKET REVENUE, BY TYPE, (2014 - 2022) ($MN)
      • FIGURE 32     IMPLANTABLE BIOMATERIALS GLOBAL MARKET REVENUE, BY TYPE, (2014 - 2022) ($MN)
      • FIGURE 33     NORTH AMERICA IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2015 V/S 2022) ($MN)
      • FIGURE 34     NORTH AMERICA IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION (2015 V/S 2022) ($MN)
      • FIGURE 35     NORTH AMERICA METALLIC IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY COUNTRY (2015 V/S 2022) (%)
      • FIGURE 36     U.S. IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2015 V/S 2022) ($MN)
      • FIGURE 37     U.S. IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2015 V/S 2022) ($MN)
      • FIGURE 38     OTHERS NORTH AMERICAN MARKET REVENUE, BY TYPE, (2015 V/S 2022) ($MN)
      • FIGURE 39     OTHERS NORTH AMERICAN MARKET REVENUE, BY APPLICATION, (2015 V/S 2022) ($MN)
      • FIGURE 40     EUROPE IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2015 V/S 2022) ($MN)
      • FIGURE 41     EUROPE IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2015 V/S 2022) ($MN)
      • FIGURE 42     EUROPEAN IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY COUNTRY, (2015 V/S 2022) (%)
      • FIGURE 43     GERMANY IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2015 V/S 2022) ($MN)
      • FIGURE 44     GERMANY IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2015 V/S 2022) ($MN)
      • FIGURE 45     U.K. IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2015 V/S 2022) ($MN)
      • FIGURE 46     U.K. IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2015 V/S 2022) ($MN)
      • FIGURE 47     FRANCE IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2015 V/S 2022) ($MN)
      • FIGURE 48     FRANCE IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2015 V/S 2022) ($MN)
      • FIGURE 49     OTHER EUROPEAN COUNTRIES IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2015 V/S 2022) ($MN)
      • FIGURE 50     OTHERS IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2015 V/S 2022) ($MN)
      • FIGURE 51     ASIA-PACIFIC IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2015 V/S 2022) ($MN)
      • FIGURE 52     ASIA-PACIFIC IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2015 V/S 2022) ($MN)
      • FIGURE 53     ASIA-PACIFIC IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY COUNTRY, (2015 V/S 2022) (%)
      • FIGURE 54     JAPAN IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2015 V/S 2022) ($MN)
      • FIGURE 55     JAPAN IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2015 V/S 2022) ($MN)
      • FIGURE 56     CHINA IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2015 V/S 2022) ($MN)
      • FIGURE 57     CHINA IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2015 V/S 2022) ($MN)
      • FIGURE 58     INDIA IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2015 V/S 2022) ($MN)
      • FIGURE 59     INDIA IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2015 V/S 2022) ($MN)
      • FIGURE 60     OTHERS IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2015 V/S 2022) ($MN)
      • FIGURE 61     OTHERS IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2015 V/S 2022) ($MN)
      • FIGURE 62     ROW IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2015 V/S 2022) ($MN)
      • FIGURE 63     ROW IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2015 V/S 2022) ($MN)
      • FIGURE 64     ROW IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY COUNTRY, (2015 V/S 2022) (%)
      • FIGURE 65     LATIN AMERICA IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE (2015 V/S 2022) ($MN)
      • FIGURE 66     LATIN AMERICA IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2015 V/S 2022) ($MN)
      • FIGURE 67     MIDDLE EAST IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE (2015 V/S 2022) ($MN)
      • FIGURE 68     MIDDLE EAST IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION (2015 V/S 2022) ($MN)
      • FIGURE 69     OTHERS IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY TYPE, (2015 V/S 2022) ($MN)
      • FIGURE 70     OTHERS IMPLANTABLE BIOMATERIALS MARKET REVENUE, BY APPLICATION, (2015 V/S 2022) ($MN)
      • FIGURE 71     SWOT: CARPENTER TECHNOLOGY CORPORATION
      • FIGURE 72     SWOT: COLLAGEN SOLUTIONS PLC
      • FIGURE 73     SWOT: CARBION NV
      • FIGURE 74     SWOT: EVONIK
      • FIGURE 75     SWOT: JOHNSON MATTHEY PLC
      • FIGURE 76     SWOT: LANDEC CORPORATION
      • FIGURE 77     SWOT: MATERION CORPORATION
      • FIGURE 78     SWOT: MORGAN ADVANCED MATERIALS PLC
      • FIGURE 79     SWOT: ROYAL DSM BIOMEDICAL, INC.
      • FIGURE 80     SWOT: SOLVAY
      • FIGURE 81     SWOT: VICTREX PLC

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     3-D MATRIX, LTD.
      • 2     3M ADVANCED MATERIALS (CERADYNE INC)
      • 3     AAP BIOMATERIALS GMBH
      • 4     ABBOTT BALL COMPANY, INC.
      • 5     ABLTI CORPORATION
      • 6     AC TECHNOLOGIES, INC.
      • 7     ADVANCED TECHNOLOGY & MATERIALS CORP.
      • 8     ADVANSOURCE BIOMATERIALS CORPORATION
      • 9     ALLOSOURCE
      • 10     ALLOYS INTERNATIONAL, INC.
      • 11     AMEDICA CORPORATION
      • 12     AUGMA BIOMATERIALS LTD.
      • 13     BARAT CERAMICS GMBH
      • 14     BERKELEY ADVANCED BIOMATERIALS, INC.
      • 15     BIOCOMPOSITES LTD.
      • 16     CALIX CERAMIC SOLUTIONS
      • 17     CAM BIOCERAMICS BV
      • 18     CARPENTER TECHNOLOGY CORPORATION
      • 19     CDM TITANIUM
      • 20     CELANESE CORPORATION3
      • 21     CELLULOSE SOLUTIONS
      • 22     CERAMTEC GMBH
      • 23     CHEMVIRON CARBON
      • 24     CLARIANT
      • 25     COLLAGEN MATRIX, INC.
      • 26     COLLAGEN SOLUTIONS PLC
      • 27     COORSTEK, INC.
      • 28     CORBION N.V.
      • 29     DAIKIN AMERICA, INC.
      • 30     DOW CORNING CORPORATION
      • 31     E. I. DU PONT DE NEMOURS AND COMPANY
      • 32     EDELSTAHLZIEHEREI MARK MANUFACTURES
      • 33     ELASTAGEN PTY LTD
      • 34     EINCO BIOMATERIAL LTDA.
      • 35     EVONIK INDUSTRIES AG
      • 36     FORT WAYNE METALS
      • 37     HERMITH GMBH
      • 38     HITACHI, LTD.
      • 39     JELLAGEN PTY LTD
      • 40     JOHNSON MATTHEY PLC
      • 41     KYOCERA CORPORATION
      • 42     LANDEC CORPORATION
      • 43     MACHINED CERAMICS, INC.
      • 44     MAGNESIUM ELEKTRON
      • 45     MARUWA CO., LTD
      • 46     MATERION CORPORATION
      • 47     MEDISIL CORPORATION
      • 48     MIDATECH
      • 49     MITSUBOSHI BELTING LTD
      • 50     MORGAN ADVANCED MATERIALS PLC
      • 51     NOBLE BIOMATERIALS INC.
      • 52     NORAKER
      • 53     NUSIL TECHNOLOGY LLC
      • 54     OLYMPUS TERUMO BIOMATERIALS CORPORATION
      • 55     PERFORMANCE PLASTICS LTD.
      • 56     Q-MED AB
      • 57     RAUSCHERT STEINBACH GMBH
      • 58     RELIANCE INDUSTRIES LIMITED
      • 59     ROYAL DSM
      • 60     RTP COMPANY
      • 61     SABIC
      • 62     SAN JOSE DELTA
      • 63     SEIKAGAKU CORP.
      • 64     SHANGHAI MEIDONG BIOMATERIALS CO., LTD
      • 65     SHENYANG TOP NEW MATERIAL CO., LTD.
      • 66     SIGMA-ALDRICH CO. LLC
      • 67     SIGMAGRAFT, INC.
      • 68     SIGMUND COHN PLATINUM
      • 69     SOLVAY ADVANCED POLYMERS, LLC
      • 70     STAINLESS SALES CORPORATION
      • 71     STANFORD CHEMICALS
      • 72     STARCH MEDICAL, INC.
      • 73     T&D MATERIAL MFG. LTD
      • 74     T.Q. ABRASIVE MACHINING
      • 75     THE LUBRIZOL CORPORATION
      • 76     TICONA GMBH
      • 77     TOSOH CORPORATION
      • 78     ULBRICH STAINLESS STEELS & SPECIAL METALS INC
      • 79     VERICEL CORPORATION
      • 80     VICTREX PLC (INVIBIO BIOMATERIAL SOLUTIONS )
      • 81     VORNIA BIOMATERIALS
      • 82     VSMPO-AVISMA
      • 83     VULCANIUM METALS INTERNATIONAL, LLC.
      • 84     XIAMEN INNOVACERA ADVANCED MATERIALS CO., LTD
      • 85     XYLOS CORPORATION
      • 86     ZEUS BIOMATERIALS